Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
Submitted by
admin
on June 12, 2017 - 9:37pm
Source:
Endpoints
News Tags:
Merck
Keytruda
clinical trials
Multiple Myeloma
Headline:
Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
Do Not Allow Advertisers to Use My Personal information
